Skip to main content

Table 1 Characteristics of patients

From: Impact of parathyroidectomy on cardiovascular outcomes and survival in chronic hemodialysis patients with secondary hyperparathyroidism. A retrospective study of 50 cases prior to the calcimimetics era

 

Surgical group

Medical group

p value

Age* (years)

51.5 ± 10.89

55 ± 11.20

0.75

Female (%)

63.3

60

n.s.

Dialysis vintage* (years)

12.9 ± 8

10 ± 1.96

n.s.

iPTH* (pmol/L)

142.08 ± 64.01

102.94 ± 32.51

0.03

Ca* (mmol/L)

2.5 ± 0.45

2.4 ± 0,65

n.s.

Anemia (%) (Hb7-<12 gr/dl)**

100

100

n.s.

ESA use (%)

100

100

n.s.

  1. *All data were expressed as mean ± standard deviation; p < 0.05 was considered statistically significant.
  2. **Classification according to the Royal College of Physicians (UK) National Clinical Guideline Centre
  3. ESA = Erythropoiesis-stimulating agent
  4. n.s. = non significant
Back to article page

BMC Surgery

ISSN: 1471-2482

Contact us